SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-21-002873
Filing Date
2021-01-19
Accepted
2021-01-19 16:37:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea133565-8k_fsdevelopment.htm 425 24985
2 PRESS RELEASE, DATED JANUARY 19, 2021 ea133565ex99-1_fsdevelopment.htm EX-99.1 11719
  Complete submission text file 0001213900-21-002873.txt   38382
Mailing Address C/O FORESITE CAPITAL, 600 MONTGOMERY ST SUITE 4500 SAN FRANCISCO CA 94111
Business Address C/O FORESITE CAPITAL, 600 MONTGOMERY ST SUITE 4500 SAN FRANCISCO CA 94111 (415) 877-4887
FS Development Corp. (Filed by) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FORESITE CAPITAL, 600 MONTGOMERY ST SUITE 4500 SAN FRANCISCO CA 94111
Business Address C/O FORESITE CAPITAL, 600 MONTGOMERY ST SUITE 4500 SAN FRANCISCO CA 94111 (415) 877-4887
FS Development Corp. (Subject) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-39438 | Film No.: 21535972
SIC: 2834 Pharmaceutical Preparations